ASBPW
Aspire Biopharma Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.02
+31.33%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+4.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 10, 2025 | Fell Donald G. · director | Purchase | 10,500 | $0.39 |
| Jun 10, 2025 | Fell Donald G. · director | Purchase | 9,500 | $0.39 |
| Jun 6, 2025 | Fell Donald G. · director | Purchase | 10,500 | $0.39 |
| Jun 6, 2025 | Fell Donald G. · director | Purchase | 9,500 | $0.39 |
| Aug 22, 2023 | PowerUp Sponsor LLC · 10 percent owner | Sale | 4,317,500 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 1Increased 1Reduced 7Sold out 32
| Filer | Action | Shares | Filed |
|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Unchanged | 1,050,000 | May 15, 2026 |
| SABA CAPITAL MANAGEMENT, L.P. | Unchanged | 983,603 | May 15, 2026 |
| LINDEN ADVISORS LP | Unchanged | 899,999 | May 15, 2026 |
| ARISTEIA CAPITAL LLC | Unchanged | 681,516 | May 15, 2026 |
| TORONTO DOMINION BANK | Reduced | 516,345 | May 15, 2026 |
| SCULPTOR CAPITAL LP | Unchanged | 500,000 | May 15, 2026 |
| CLEAR STREET GROUP INC. | Reduced | 330,664 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Unchanged | 275,000 | May 15, 2026 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | Reduced | 273,000 | May 15, 2026 |
| D. E. SHAW & CO., INC. | Unchanged | 199,999 | May 15, 2026 |
| WOLVERINE ASSET MANAGEMENT LLC | Unchanged | 197,144 | May 4, 2026 |
| VERITION FUND MANAGEMENT LLC | Reduced | 191,021 | May 15, 2026 |
| CONTEXT CAPITAL MANAGEMENT, LLC | Unchanged | 175,000 | May 7, 2026 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | Unchanged | 138,536 | May 15, 2026 |
| LMR PARTNERS LLP | Unchanged | 125,000 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 10, 2025